Kyle P. Chiang

2.2k total citations
25 papers, 1.7k citations indexed

About

Kyle P. Chiang is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Kyle P. Chiang has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Organic Chemistry. Recurrent topics in Kyle P. Chiang's work include RNA Research and Splicing (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Alzheimer's disease research and treatments (4 papers). Kyle P. Chiang is often cited by papers focused on RNA Research and Splicing (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Alzheimer's disease research and treatments (4 papers). Kyle P. Chiang collaborates with scholars based in United States, Hong Kong and Germany. Kyle P. Chiang's co-authors include Benjamin F. Cravatt, Jack C. Sipe, Ernest Beutler, Alexandra Lehmkuhl Gerber, Jeffery W. Kelly, Evan T. Powers, Hans E. Purkey, Tom W. Muir, Sherry Niessen and Alan Saghatelian and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Kyle P. Chiang

25 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle P. Chiang United States 20 886 511 297 257 210 25 1.7k
Federica Vacondio Italy 29 829 0.9× 656 1.3× 543 1.8× 369 1.4× 155 0.7× 85 2.1k
Marya Liimatta United States 19 852 1.0× 871 1.7× 200 0.7× 296 1.2× 288 1.4× 23 2.0k
Armand B. Cognetta United States 15 728 0.8× 312 0.6× 324 1.1× 107 0.4× 119 0.6× 15 1.2k
Brian Lockhart France 24 956 1.1× 380 0.7× 352 1.2× 450 1.8× 518 2.5× 51 2.0k
Jason E. Savage United States 19 1.3k 1.5× 255 0.5× 244 0.8× 553 2.2× 377 1.8× 38 2.6k
K.W. Nettles United States 30 1.5k 1.7× 179 0.4× 410 1.4× 191 0.7× 194 0.9× 54 2.9k
Andrew D. White United States 18 1.1k 1.3× 166 0.3× 666 2.2× 260 1.0× 224 1.1× 37 2.0k
David A. Griffith United States 22 1.2k 1.4× 249 0.5× 880 3.0× 247 1.0× 349 1.7× 52 2.5k
Paul M. Epstein United States 26 1.5k 1.7× 320 0.6× 226 0.8× 229 0.9× 250 1.2× 64 2.0k
James E. Audia United States 24 1.6k 1.8× 337 0.7× 561 1.9× 432 1.7× 829 3.9× 64 3.1k

Countries citing papers authored by Kyle P. Chiang

Since Specialization
Citations

This map shows the geographic impact of Kyle P. Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle P. Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle P. Chiang more than expected).

Fields of papers citing papers by Kyle P. Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle P. Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle P. Chiang. The network helps show where Kyle P. Chiang may publish in the future.

Co-authorship network of co-authors of Kyle P. Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle P. Chiang. A scholar is included among the top collaborators of Kyle P. Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle P. Chiang. Kyle P. Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shengwen, Susana Gordo, Elizabeth A. McCarthy, et al.. (2022). Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia. PLoS ONE. 17(9). e0274774–e0274774. 5 indexed citations
2.
Chandler, Randy J., Brandon T. Hubbard, Jessica L. Schneller, et al.. (2020). Promoterless, Nuclease‐Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia. Hepatology. 73(6). 2223–2237. 43 indexed citations
3.
Adams, Ryan A., Cátia Fernandes‐Cerqueira, Antonella Notarnicola, et al.. (2019). Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses. Cellular and Molecular Immunology. 18(6). 1463–1475. 26 indexed citations
5.
Lo, Wing‐Sze, Elisabeth Gardiner, Zhiwen Xu, et al.. (2014). Human tRNA synthetase catalytic nulls with diverse functions. Science. 345(6194). 328–332. 91 indexed citations
6.
Zhou, Jie, Feng Wang, Zhiwen Xu, et al.. (2014). Secreted Histidyl-tRNA Synthetase Splice Variants Elaborate Major Epitopes for Autoantibodies in Inflammatory Myositis. Journal of Biological Chemistry. 289(28). 19269–19275. 42 indexed citations
7.
Xu, Zhiwen, Zhiyi Wei, Jie Zhou, et al.. (2012). Internally Deleted Human tRNA Synthetase Suggests Evolutionary Pressure for Repurposing. Structure. 20(9). 1470–1477. 26 indexed citations
8.
Pfeifer, Thomas, Prakash G. Chandak, Achim Lass, et al.. (2010). Cholesteryl ester hydrolase activity is abolished in HSL macrophages but unchanged in macrophages lacking KIAA1363. Journal of Lipid Research. 51(10). 2896–2908. 42 indexed citations
9.
Pratt, Matthew R., Matthew D. Sekedat, Kyle P. Chiang, & Tom W. Muir. (2009). Direct Measurement of Cathepsin B Activity in the Cytosol of Apoptotic Cells by an Activity-Based Probe. Chemistry & Biology. 16(9). 1001–1012. 32 indexed citations
10.
Chiang, Kyle P., Mette S. Jensen, Robert K. McGinty, & Tom W. Muir. (2009). A Semisynthetic Strategy to Generate Phosphorylated and Acetylated Histone H2B. ChemBioChem. 10(13). 2182–2187. 55 indexed citations
11.
Chiang, Kyle P. & Tom W. Muir. (2008). Systems- and Molecular-Level Elucidation of Signaling Processes Through Chemistry. Science Signaling. 1(42). pe45–pe45. 2 indexed citations
12.
Chiang, Kyle P., Sherry Niessen, Alan Saghatelian, & Benjamin F. Cravatt. (2006). An Enzyme that Regulates Ether Lipid Signaling Pathways in Cancer Annotated by Multidimensional Profiling. Chemistry & Biology. 13(10). 1041–1050. 162 indexed citations
13.
Nomura, Daniel K., Kathleen A. Durkin, Kyle P. Chiang, et al.. (2006). Serine Hydrolase KIAA1363:  Toxicological and Structural Features with Emphasis on Organophosphate Interactions. Chemical Research in Toxicology. 19(9). 1142–1150. 27 indexed citations
14.
Razavi, Hossein, Evan T. Powers, Hans E. Purkey, et al.. (2005). Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(4). 1075–1078. 42 indexed citations
15.
Nomura, Daniel K., Donmienne Leung, Kyle P. Chiang, et al.. (2005). A brain detoxifying enzyme for organophosphorus nerve poisons. Proceedings of the National Academy of Sciences. 102(17). 6195–6200. 42 indexed citations
16.
Petrassi, H. Michael, Steven M. Johnson, Hans E. Purkey, et al.. (2005). Potent and Selective Structure-Based Dibenzofuran Inhibitors of Transthyretin Amyloidogenesis:  Kinetic Stabilization of the Native State. Journal of the American Chemical Society. 127(18). 6662–6671. 61 indexed citations
18.
Razavi, Hossein, S.K. Palaninathan, Evan T. Powers, et al.. (2003). Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action. Angewandte Chemie International Edition. 42(24). 2758–2761. 200 indexed citations
19.
Razavi, Hossein, S.K. Palaninathan, Evan T. Powers, et al.. (2003). Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action. Angewandte Chemie. 115(24). 2864–2867. 37 indexed citations
20.
Oza, Vibha, Prakash Raman, Edward K. Koepf, et al.. (2001). Synthesis, Structure, and Activity of Diclofenac Analogues as Transthyretin Amyloid Fibril Formation Inhibitors. Journal of Medicinal Chemistry. 45(2). 321–332. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026